NCT02417012View on ClinicalTrials.gov

Lifestyle and Glucose Lowering Medication in T2DM

NACompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Diabetes Mellitus, Type 2
Interventions
BEHAVIORAL

U-TURN

Participants in this group will receive individual and group based interventions on obtaining and maintaining a healthy lifestyle, while having the pharmacological treatment regulated

BEHAVIORAL

Standard care

Standard individual diabetes support

Trial Locations (1)

2100

Center for Physical Activity Research, Copenhagen University Hospital, Copenhagen

All Listed Sponsors
collaborator

TRYG Foundation

OTHER

lead

Rigshospitalet, Denmark

OTHER

NCT02417012 - Lifestyle and Glucose Lowering Medication in T2DM | Biotech Hunter | Biotech Hunter